The drugmaker, which has signed semi-exclusive licensing partnerships with Lupin and Torrent Pharma, has regulatory approval to make and market semaglutide for both type 2 diabetes and weight management

Seek immediate medical attention for: Severe, persistent abdominal pain that does not resolve or worsens over hours Vomiting blood (hematemesis) or material that looks like coffee grounds Black, tarry stools (melena) or visible blood in stools, suggesting gastrointestinal bleeding Severe nausea and vomiting preventing adequate fluid intake or lasting more than 24 hours Signs of dehydration including decreased urination, dizziness, or confusion Sudden, sharp abdominal pain with rigidity, potentially indicating perforation Progressive dysphagia (difficulty swallowing) Persistent vomiting despite medication adjustments Schedule a non-urgent appointment for: Persistent upper abdominal discomfort or burning sensation lasting more than two weeks Recurrent dyspepsia not responding to dietary modifications New or worsening heartburn or acid reflux symptoms Unexplained fatigue potentially indicating anemia from chronic blood loss Unintended, disproportionate, or symptomatic weight loss distinct from expected medication effects According to American College of Gastroenterology guidelines, patients aged 60 or older with new-onset dyspepsia should undergo prompt endoscopic evaluation, as should patients of any age with alarm features

Noom GLP-1 Rx Program: Trusted, powerful, and affordable Rx Program with SmartDose, we offer patients compounded semaglutide starting at $149/month*
$52 Our products are provided in a freeze-dried, lyophilized powder that is vacuum sealed in a sterile vial format that typically require reconstitution with an applicable solvent or solution and intended for research use only
Rebates are a valuable tool for negotiating price concessions from manufacturers when there are multiple competing products
According to Table 1, comprehensive experimental and observational studies reveal that GLP-1RAs do not elevate overall cancer risk, while preclinical investigations have demonstrated multiple anti-tumor mechanisms, including proliferation inhibition, apoptosis induction, and metastasis suppression